(NRG-GU001) Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/pT4 Urothelial Bladder Cancer
Description: 

To evaluate the ability of post-cystectomy adjuvant radiotherapy to safely reduce pelvic tumor recurrence, defined as pelvic recurrence-free survival.

Study Number: 

NCG 271915

Phase: 
2
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT02316548

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.